成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Toggle Nav
Close
  • Menu
  • Setting

NVP-CGM097

Catalog No.
B4677
potent and selective MDM2 inhibitor
Grouped product items
SizePriceStock Qty
2mg
$110.00
Ship with 10-15 days
5mg
$209.00
Ship with 10-15 days
10mg
$352.00
Ship with 10-15 days
50mg
$835.00
Ship with 10-15 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Chemical Properties

StorageStore at -20°C
M.Wt659.26
Cas No.1313363-54-0
FormulaC38H47ClN4O4
SolubilitySoluble in DMSO
Chemical Name(S)-1-(4-chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-(methyl(((1r,4S)-4-(4-methyl-3-oxopiperazin-1-yl)cyclohexyl)methyl)amino)phenyl)-1,2-dihydroisoquinolin-3(4H)-one
SDFDownload SDF
Canonical SMILESCC(OC(C=C1[C@]2([H])C3=CC=C(Cl)C=C3)=C(OC)C=C1CC(N2C4=CC=C(N(C[C@@]5([H])CC[C@@](N(CC6=O)CCN6C)([H])CC5)C)C=C4)=O)C
Shipping ConditionSmall Molecules with Blue Ice, Modified Nucleotides with Dry Ice.
General tips We do not recommend long-term storage for the solution, please use it up soon.

Protocol

Cell experiment [1,2]:

Cell lines

Neuroblastoma cell lines, HCT116 cells

Preparation method

Soluble in DMSO. General tips for obtaining a higher concentration: Please warm the tube at 37 ℃ for 10 minutes and/or shake it in the ultrasonic bath for a while. Stock solution can be stored below -20℃ for several months.

Reacting condition

24 h

Applications

The combination of NVP-CGM097 with NVP-LDK378 promoted apoptosis in ALK mutant and p53 WT neuroblastoma cell lines. NVP-LDK378 inhibited ALK phosphorylation and NVP-CGM097 caused induction of p53 and its downstream target genes in these cell lines. NVP-CGM097 significantly inhibited the proliferation of cells expressing wild-type p53, while sparing the p53 null cells with a 35-58-fold difference. NVP-CGM097 significantly redistributed wild-type p53 into the cell nucleus with an IC50 of 0.224 μM. NVP-CGM097 inhibited HCT116 (p53WT/WT) with IC50 of 454 ± 136 nM.

Animal experiment [1,3]:

Animal models

NOD.SCID.IL2R-/- (NSG) mice engraftmented with hCD45+/hCD19+ cells, ALK mutant neuroblastoma models, MDM2-amplified SJSA-1 human tumor model

Dosage form

Intravenous injection, 30 mg/kg, Daily

Application

In NOD.SCID.IL2R-/- (NSG) mice engraftmented with hCD45+/hCD19+ cells, CGM097 ultimately became moribund from progressive leukemia. CGM097 significantly upregulated the expression of 11 genes at the 26 hour timepoint, including the canonical p53 targets BBC3, CDKN1A and MDM2. CGM097 markedly improved overall survival. NVP-LDK378 and NVP-CGM097 combination resulted in complete tumor regression and markedly prolonged survival in neuroblastoma xenograft models. NVP-CGM097 inhibited the interaction between p53 and MDM2 and reactivated the p53 pathway in a MDM2-amplified SJSA-1 human tumor model. NVP-CGM097 (30 mg/kg) increased p21 mRNA levels in tumor-bearing rats. Daily treatment with NVP-CGM097 dose-dependently inhibited SJSA-1 tumor growth in rats.

Other notes

Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal.

References:

[1]. Wang H Q, Battalagine L, Liang J, et al. The Mdm2 inhibitor NVP-CGM097 enhances the anti-tumor activity of NVP-LDK378 in ALK mutant neuroblastoma models[J]. 2014.

[2]. Holzer P, et al. Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors. J Med Chem. 2015 Aug 27;58(16):6348-58.

[3]. Townsend E C, DeSouza T, Murakami M A, et al. The MDM2 Inhibitor NVP-CGM097 Is highly active in a randomized preclinical trial of B-cell acute lymphoblastic leukemia patient derived xenografts[J]. 2015.

Quality Control

Quality Control & MSDS

View current batch:

Chemical structure

NVP-CGM097